Sign In
Get Clay Free →

Suggestions

    Ed Seguine

    Pharma Technology Executive and Investor

    Ed Seguine is no longer the CEO of Clinical Ink. He served as the CEO of Clinical Ink for nearly fourteen years until February 2023, when he was succeeded by Dr. Jonathan Goldman.2 During his tenure, Ed led Clinical Ink to significant growth, doubling sales in the two years leading up to 2019.1

    As of October 2024, Ed Seguine has taken on a new role as the Chief Executive Officer of Elemental Machines, a company that develops intelligent operations platforms for life sciences.3 In his career spanning over 30 years, Ed has held various leadership positions in technology and life sciences companies. He has been a repeat CEO, founder, and investor.3

    Prior to his time at Clinical Ink, Ed's experience included:

    • General Manager at Medidata Solutions
    • CEO of Fast Track Systems (which was later acquired by Medidata)
    • Venture Investor/Finance Manager at Eli Lilly
    • Director of Finance for Action Target

    Ed Seguine holds a bachelor's degree in finance from Brigham Young University, an MBA from Indiana University's Kelley School of Business, and an executive certificate in Strategy and Innovation from the MIT Sloan School of Management.1

    Highlights

    Dec 9 · clinicalink.com
    Innovation and Growth - Clinical ink
    Elemental Machines Announces Edward Seguine As New Chief ...
    Feb 13 · clinicalink.com
    Jonathan Goldman | New CEO at Clinical ink
    Nov 15 · leadiq.com
    Clinical ink Company Overview, Contact Details & Competitors
    Mar 22 · ashtontweed.com
    CEO Leadership Series: Ed Seguine, CEO, Clinical Ink

    Related Questions

    What are Ed Seguine's key achievements at Clinical Ink?
    How did Ed Seguine's previous roles prepare him for his position at Clinical Ink?
    What strategies did Ed Seguine implement to drive growth at Clinical Ink?
    How has Ed Seguine's leadership impacted Clinical Ink's technology and innovation?
    What are Ed Seguine's future plans for Clinical Ink?
    Ed Seguine
    Ed Seguine, photo 1
    Ed Seguine, photo 2
    Add to my network

    Location

    Greater Philadelphia Area